Text Size
15 studies found for:    Ustekinumab | Open Studies

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting Tacrolimus, Sirolimus and Ustekinumab vs. Tacrolimus and Sirolimus for the Prevention of Acute Graft-Versus-Host Disease
Condition: Acute GVH Disease
Interventions: Drug: Ustekinumab;   Drug: Placebo
2 Recruiting A Study to Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease (IM-UNITI)
Conditions: Crohn's Disease;   Colitis;   IBD;   Inflammatory Bowel Disease
Interventions: Drug: Placebo;   Drug: Ustekinumab
3 Recruiting Pilot Study of Ustekinumab for Subjects With Chronic Atopic Dermatitis
Condition: Atopic Dermatitis
Interventions: Drug: Ustekinumab;   Other: Placebo
4 Recruiting A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease (UNITI-2)
Conditions: Crohn's Disease;   Inflammatory Bowel Disease;   IBD;   Colitis
Interventions: Drug: Group 3: ustekinumab approximately 6 mg/kg;   Drug: Group 1: Placebo;   Drug: Group 2 ustekinumab 130 mg
5 Not yet recruiting A Study to Evaluate the Effectiveness of STELARA ™ (USTEKINUMAB) in the Treatment of Scalp Psoriasis
Conditions: Scalp Psoriasis;   Plaque Psoriasis
Interventions: Drug: Ustekinumab;   Drug: Placebo
6 Recruiting A Study of Efficacy and Safety of Ustekinumab in Patients With Primary Biliary Cirrhosis (PBC) Who Had an Inadequate Response to Ursodeoxycholic Acid
Condition: Primary Biliary Cirrhosis
Interventions: Drug: ustekinumab (double-blind);   Drug: ustekinumab (open-label);   Drug: Placebo
7 Not yet recruiting Ustekinumab for Active Sight-Threatening Uveitis
Condition: Uveitis
Intervention: Drug: Ustekinumab
8 Recruiting Ustekinumab Quality of Life Study
Condition: Psoriasis
Intervention: Drug: Ustekinumab
9 Recruiting Study of Efficacy and Safety of Brodalumab Compared With Placebo and Ustekinumab in Moderate to Severe Plaque Psoriasis Subjects
Condition: Moderate to Severe Plaque Psoriasis
Interventions: Drug: 210 mg brodalumab;   Drug: 140 mg brodalumab;   Drug: ustekinumab;   Drug: placebo
10 Recruiting Study of Efficacy and Safety of Brodalumab Compared With Placebo and Ustekinumab in Moderate to Severe Plaque Psoriasis Subjects
Condition: Moderate to Severe Plaque Psoriasis
Interventions: Drug: 210 mg brodalumab;   Drug: 140 mg brodalumab;   Drug: ustekinumab;   Drug: placebo
11 Recruiting Swiss Dermatology Network of Targeted Therapies (SDNTT)
Condition: Psoriasis
Interventions: Biological: Adalimumab;   Biological: Etanercept;   Biological: Infliximab;   Biological: Ustekinumab;   Drug: Cyclosporine A;   Drug: Fumaric acids;   Drug: Methotrexate;   Drug: Other anti-psoriatic systemic treatments
12 Recruiting Psoriasis Longitudinal Assessment and Registry (PSOLAR)
Conditions: Psoriasis;   Arthritis, Psoriatic
Interventions: Biological: ustekinumab;   Biological: Biological therapies other than infliximab and ustekinumab;   Drug: conventional systemic agents;   Biological: infliximab
13 Recruiting PsoBest - The German Psoriasis Registry
Conditions: Psoriasis;   Psoriatic-arthritis
Intervention:
14 Not yet recruiting Economic Evaluation of Systemic Treatments for Moderate-to-severe Psoriasis
Condition: Psoriasis
Interventions: Drug: Methotrexate;   Drug: Cyclosporins;   Drug: fumaric acid;   Drug: Acitretin;   Drug: Infliximab;   Drug: etanercept;   Drug: Adalimumab;   Drug: Ustekinumab
15 Recruiting Cardiovascular Risk Assessment in Patients With Severe Psoriasis Treated With Biologic Agents
Conditions: Psoriasis;   Atherosclerosis
Intervention: Drug: biological treatment
To Top

† Indicates status has not been verified in more than two years